Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Nova Stream

 

Singapore group buys gynaecology clinics specialist

Publicly listed outpatient network Singapore Medical Group (SMG) is buying six-clinic gynaecologist Astra Women's Specialists for S$60m. The announcement has prompted the second spike in its share price this year, following its purchase of imaging specialist Lifescan in August.

Dr Agarwal plans further African expansion

The Indian eye care chain Dr Agarwal won’t cure its itchy feet, and after opening in two new African countries this summer has taken its total investment on the continent to US$15m. Managing director S. Rajagopalan told Healthcare Nova at the African Health Business Symposium in Kenya how it makes money on a continent where it's now reached one million patients.

Egyptian investor close to making acquisitions in Africa

The Egyptian investor Rx Health Management is close to committing most of its US$50m Egyptian fund and is close to making acquisitions in Africa. We speak to CEO and chairman Professor Hatem Elgabaly to find out more.

Healthcare Nova September 2016

Click here to see your September 2016 edition of Healthcare Nova Here is our roundup of news for September, including details of Singapore-based Fullerton's plans to IPO, the effect of austerity biting in Abu Dhabi, and our financial review and comparison of international hospital groups - plus an in-depth feature on the future of healthcare in Nigeria.

Kos and Apollo open rehab hospital in India

Italy's largest care provider Kos and India's largest hospital group Apollo Hospitals have opened a 64-bed rehab hospital in Hyderabad in an equal joint venture. Could this lead to a network of rehab facilities across India?

GVM to launch its first China facility in early 2017

Days after opening a €3m diagnostics centre in Moscow, Italian hospital operator Gruppo Villa Maria (GVM) says its first facility in China is to launch early next year. We speak to vice-president Bruno Biagi about the group’s international strategy.

Singapore-based Fullerton to IPO

Singapore-based healthcare provider Fullerton has received approval to list on the Singapore stock exchange, but could its S$1.5bn (almost €1bn) valuation be too high?

Find Us